Biotech Values

[mcbio]

The couple of percent deals tend to be settlements. The injunctions are always from successful lawsuits.

Thanks very much. That makes perfect sense.

One issue for MNTA here is timing - could be that the Amphastar process predates the MNTA patents.

But if they are using a process that they never got a patent on and that violates MNTA's patented process, I assume timing wouldn't be an issue.